Vital KSK Holdings, Inc. (TYO:3151)

Market Cap	66.42B +15.0%
Revenue (ttm)	604.24B +0.8%
Net Income	6.74B -7.0%
EPS	139.44 -4.7%
Shares Out	48.38M
PE Ratio	9.85
Forward PE	n/a
Dividend	68.00 (4.95%)
Ex-Dividend Date	Mar 30, 2026

Volume	125,600
Average Volume	109,795
Open	1,383.00
Previous Close	1,373.00
Day's Range	1,360.00 - 1,384.00
52-Week Range	1,102.00 - 1,473.00
Beta	0.22
RSI	39.53
Earnings Date	Feb 10, 2026

About Vital KSK Holdings

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2009
• Employees: 3,756
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3151

Financial Performance

In fiscal year 2025, Vital KSK Holdings's revenue was 600.37 billion, an increase of 2.19% compared to the previous year's 587.48 billion. Earnings were 7.31 billion, an increase of 25.07%.